Bayer AG (BAYZF)
50.53
+1.04
(+2.11%)
USD |
OTCM |
Oct 06, 16:00
Bayer EPS Diluted (Quarterly) : 0.2592 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2592 |
| March 31, 2026 | 3.290 |
| December 31, 2025 | -4.451 |
| September 30, 2025 | -1.146 |
| June 30, 2025 | -0.2296 |
| March 31, 2025 | 1.392 |
| December 31, 2024 | -0.3637 |
| September 30, 2024 | -4.677 |
| June 30, 2024 | -0.0373 |
| March 31, 2024 | 2.210 |
| December 31, 2023 | 1.464 |
| September 30, 2023 | -5.059 |
| June 30, 2023 | -2.090 |
| March 31, 2023 | 2.379 |
| December 31, 2022 | 0.6344 |
| September 30, 2022 | 0.5595 |
| June 30, 2022 | -0.3228 |
| March 31, 2022 | 3.758 |
| December 31, 2021 | 1.351 |
| September 30, 2021 | 0.102 |
| June 30, 2021 | -2.863 |
| March 31, 2021 | 2.561 |
| December 31, 2020 | 0.3738 |
| September 30, 2020 | -3.265 |
| June 30, 2020 | -10.70 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.670 |
| December 31, 2019 | 1.594 |
| September 30, 2019 | 1.172 |
| June 30, 2019 | 0.4624 |
| March 31, 2019 | 1.438 |
| December 31, 2018 | -4.801 |
| September 30, 2018 | 3.407 |
| June 30, 2018 | 1.033 |
| March 31, 2018 | 2.709 |
| December 31, 2017 | 0.197 |
| September 30, 2017 | 5.144 |
| June 30, 2017 | 1.494 |
| March 31, 2017 | 2.507 |
| December 31, 2016 | 0.5661 |
| September 30, 2016 | 1.576 |
| June 30, 2016 | 1.856 |
| March 31, 2016 | 1.986 |
| December 31, 2015 | 0.7971 |
| September 30, 2015 | 1.324 |
| June 30, 2015 | 1.531 |
| March 31, 2015 | 1.785 |
| December 31, 2014 | 0.3319 |
| September 30, 2014 | 1.304 |
| June 30, 2014 | 1.552 |
| March 31, 2014 | 2.319 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| SenesTech, Inc. | -0.3454 |
| Dermapharm Holding SE | 0.5451 |
| Johnson & Johnson | 2.268 |
| Merck & Co., Inc. | -0.5405 |
| Pfizer Inc. | -0.0435 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 266.26M |
| Revenue (Quarterly) | 12.64B |
| Total Expenses (Quarterly) | 12.39B |
| Enterprise Value | 88.82B |
| Gross Profit Margin (Quarterly) | 58.24% |
| Profit Margin (Quarterly) | 2.11% |
| Earnings Yield | -4.05% |
| Operating Earnings Yield | 14.73% |
| Normalized Earnings Yield | 3.910 |